HQL Equity Ratio

abrdn Life Sciences Investors Shares of Beneficial Interest · Equity Ratio

HQL logo

HQL Equity Ratio

Current (TTM)99.57%
HQL Equity Ratio (99.51% → 99.57%)
High-resolution chart · PNG

HQL equity ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

abrdn Life Sciences Investors Shares of Beneficial Interest Equity Ratio — Annual fiscal periods
Period endingEquity Ratio
99.6651%
99.8071%
99.8343%
95.9436%
97.9885%
99.8771%
99.1393%
99.3776%
99.5769%
99.3631%
98.9283%
99.8305%
99.825%
99.8221%
99.4172%
97.8972%
93.7759%
98.8612%
99.6441%
99.003%
99.5658%
99.3268%
98.6528%
99.81%
99.6758%
98.6193%
99.8487%
99.515%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.